Colin Sheldrake
Head of Device Development
Management
OptiNose
Norway
Biography
Colin Sheldrake has been with OptiNose since 2004 and as Head of Device Development is responsible for the design, development and manufacturing scale-up of OptiNose’s nasal delivery devices. He also chairs OptiNose’s patent committee to ensure the intellectual property portfolio and patent filing is in line with the business need.
Research Interest
 Pharmaceuticals
